CENTRALPHARMA COMMUNICATIONS OÜ - 10640025 | ScoreStorybook | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

CENTRALPHARMA COMMUNICATIONS OÜ

Summary report

Date of report 07.01.2025

CENTRALPHARMA COMMUNICATIONS OÜ
10640025 - Registered
Founded in 28.01.2000
Fixed capital 2,556 €

Former names

  • Osaühing Tsentraalfarmaatsia
VAT  
EE100629860 (start 01.08.2000)
start end
01.08.2000 -

Add CENTRALPHARMA COMMUNICATIONS OÜ data to your system

download JSON download CSV

Add CENTRALPHARMA COMMUNICATIONS OÜ data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

Don't have CRM? Read more

keywords

  • esindused
  • rahvusvahelised organisatsioonid
  • riik ja ühiskond
  • ühingud
  • ärinõustamine

CENTRALPHARMA COMMUNICATIONS OÜ

Scores and ratings

Reputation score

What is Reputation score?

Credit Score

Trustworthy 0.01

Loader

What is Credit Score?

Open the reports you want to print

Employees and salaries

CENTRALPHARMA COMMUNICATIONS OÜ

Number of employees and estimated average salaries
?

CENTRALPHARMA COMMUNICATIONS OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................
2016 II........................
2016 I........................
2015 IV........................
2015 III........................
2015 II........................
2015 I........................

Deciders and beneficiaries

CENTRALPHARMA COMMUNICATIONS OÜ

Decision-makers
?

Former decision-makers

Kadri Känd

Relations: 2
Turnover 2024: 887 196 €
Employees: 6
Kadri Känd
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 2240

Date of birth: ......

Active relations 2

Business adviceReal Estate Rental
*

CENTRALPHARMA COMMUNICATIONS OÜ

Former decision-makers
?

Erki Vään

Relations: 9
Turnover 2024: 33 084 000 €
Employees: 21
Erki Vään
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 15350

Date of birth: ......

Active relations 9

Cargo forwardingTruck rentalBusiness adviceMediation of a variety of goodsFreight on the roadActivities of housing associationsActivities of sports clubs

Rainar Aamisepp

Relations: 2
Turnover 2024: 49 915 002 €
Employees: 322
Rainar Aamisepp
★★★★

......

Related companies scores

Credit Score: Borderline

Reputation score: 22400

Date of birth: ......

Active relations 2

Activities of medical laboratoriesReal Estate Rental

CENTRALPHARMA COMMUNICATIONS OÜ

History of right of representation
?
Field
Professional Activities
Business age
24y
Beneficial country:
Estonia
 
Kadri Känd ... - ...
Rainar Aamisepp ... - ...
Erki Vään ... - ...
2000
2004
2007
2011
2014
2018
2021
2025
2000
2002
2005
2007
2009
2011
2014
2016
2018
2020
2023
2025

CENTRALPHARMA COMMUNICATIONS OÜ

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
0.01
..................
0.01
..................
0.41
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

CENTRALPHARMA COMMUNICATIONS OÜ ...

Goodwill

CENTRALPHARMA COMMUNICATIONS OÜ

Taxes paid and estimated average salaries

CENTRALPHARMA COMMUNICATIONS OÜ

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................
2016 IV* ............* ..............................
2016 III* ............* ..............................
2016 II* ............* ..............................
2016 I* ............* ..............................
2015 IV* ............* ..............................
2015 III* ............* ..............................
2015 II* ............* ..............................
2015 I* ............* ..............................

CENTRALPHARMA COMMUNICATIONS OÜ

Sales revenue by business area

CENTRALPHARMA COMMUNICATIONS OÜ ...

Sales revenue by country

CENTRALPHARMA COMMUNICATIONS OÜ ...

Financial indicators and prognosis

CENTRALPHARMA COMMUNICATIONS OÜ ...

Financial raiting: "VERY GOOD" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

CENTRALPHARMA COMMUNICATIONS OÜ

Real estate as of 07.01.2025

Active and unactive real estate

igon P......
igon P......
igon J......
igon L......
igon L......

CENTRALPHARMA COMMUNICATIONS OÜ

Annual reports
Year Period Submitted Report PDF
2023 01.01.2023–31.12.2023 21.06.2024 ......
2022 01.01.2022–31.12.2022 20.06.2023 ......
2021 01.01.2021–31.12.2021 29.06.2022 ......
2020 01.01.2020–31.12.2020 21.09.2021 ......
2019 01.01.2019–31.12.2019 13.08.2020 ......
2018 01.01.2018–31.12.2018 08.07.2019 ......
2017 01.01.2017–31.12.2017 29.08.2018 ......
2016 01.01.2016–31.12.2016 30.06.2017 ......
2015 01.01.2015–31.12.2015 01.07.2016 ......
2014 01.01.2014–31.12.2014 30.06.2015 ......
2013 01.01.2013–31.12.2013 29.04.2014 ......
2012 01.01.2012–31.12.2012 17.06.2013 ......
2011 01.01.2011–31.12.2011 03.07.2012 ......
2010 01.01.2010–31.12.2010 29.06.2011 ......
2009 01.01.2009–31.12.2009 27.05.2010 ......
2008 01.01.2008–31.12.2008 01.07.2009 ......
2007 01.01.2007–31.12.2007 27.06.2008 ......
2006 01.01.2006–31.12.2006 26.06.2007 ......
2005 01.01.2005–31.12.2005 30.06.2006 ......
2004 01.01.2004–31.12.2004 29.06.2005 ......
2003 01.01.2003–31.12.2003 30.06.2004 ......
2002 01.01.2002–31.12.2002 30.06.2003 ......
2001 01.01.2001–31.12.2001 01.07.2002 ......
2000 01.01.2000–31.12.2000 06.07.2001 ......

Liabilities and debts

CENTRALPHARMA COMMUNICATIONS OÜ

Credit score history and prognosis
Publish claims
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

CENTRALPHARMA COMMUNICATIONS OÜ

Reports and assets-liabilities overview 07.01.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

CENTRALPHARMA COMMUNICATIONS OÜ

Claims history
?
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Debt claims ...... €

Total debt claims: ...... €

Latest events
...... ......

CENTRALPHARMA COMMUNICATIONS OÜ

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......
2016 IV* ...... €...... €...... €...... €......
2016 III* ...... €...... €...... €...... €......
2016 II* ...... €...... €...... €...... €......
2016 I* ...... €...... €...... €...... €......
2015 IV* ...... €...... €...... €...... €......
2015 III* ...... €...... €...... €...... €......
2015 II* ...... €...... €...... €...... €......
2015 I* ...... €...... €...... €...... €......

CENTRALPHARMA COMMUNICATIONS OÜ

Bailiff's enforcement proceedings as of 07.01.2025
?

Bailiff's enforcement proceedings MISSING

CENTRALPHARMA COMMUNICATIONS OÜ

Regulations of the Payment Order Department as of 07.01.2025
?

Regulations of the Payment Order Department MISSING

CENTRALPHARMA COMMUNICATIONS OÜ

Court orders in the register as of 07.01.2025
?
Logo

Puuduste kõrvaldamise määrus

22.05.2023

Regulation number: Ä 10047070 / M3

Regulation status has entered into force: 22.05.2023

Regulation status: Allkirjastatud

CENTRALPHARMA COMMUNICATIONS OÜ

Decisions of the Consumer Disputes Committee as of 07.01.2025
?

Consumer disputes MISSING

CENTRALPHARMA COMMUNICATIONS OÜ

Court hearings as of 07.01.2025
?

Court hearings MISSING

CENTRALPHARMA COMMUNICATIONS OÜ

Rulings as of 07.01.2025
?

Court settlemets MISSING

CENTRALPHARMA COMMUNICATIONS OÜ

Notices and announcements as of 07.01.2025
?
Logo

Notice of division of a company

20.06.2023
Äriühingu jagunemise teade
Avaldamise algus: 20.06.2023
Avaldamise lõpp: tähtajatu
OÜ CentralPharma Communications (registrikood 10640025) avaldab teadaande äriseadustiku (ÄS) § 447 lõike 2¹ alusel.

Ühing teatab jagunemisest. Jagunemisel osalesid OÜ CentralPharma Communications (registrikood 10640025) ja Impresa OÜ (registrikood: 16761965), asukoht: Harju maakond, Tallinn, Haabersti linnaosa, Roostiku tn 29, 13516.

Äriühingute võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 447 lg 21). centralpharma@centralpharma.ee

Ärinimed
OÜ CentralPharma Communications, kehtetud ärinimed: Osaühing Tsentraalfarmaatsia.
OÜ CentralPharma Communications
Haabersti linnaosa, Tallinn, Harju maakond, Lesta tn 26-11
Telefon: +372 6015740
E-post: centralpharma@centralpharma.ee
Teadaande avaldaja kontaktandmed:
KADRI KÄND
Teadaande number 2086773

Marketing

Business network

CENTRALPHARMA COMMUNICATIONS OÜ

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

CENTRALPHARMA COMMUNICATIONS OÜ

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.